The Spectrum of Pseudomembranous Enterocolitis and Antibiotic-Associated Diarrhea
Open Access
- 28 October 2002
- journal article
- review article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 162 (19) , 2177-2184
- https://doi.org/10.1001/archinte.162.19.2177
Abstract
Pseudomembranous (entero)colitis is primarily caused by Clostridium difficile infection. The most common predisposing factor is prior use of antibiotics, including vancomycin and metronidazole, which themselves are therapy for C difficile colitis. Other risk factors have also been described. The presence of C difficile in the gastrointestinal tract leads to a spectrum of manifestations from the asymptomatic carrier state to fulminant colitis. Successful treatment of C difficile colitis requires prompt treatment with appropriate antibiotics, withdrawal of the suspected predisposing antibiotics, and, in rare cases, total colectomy. Preventive measures of adequate infection control and judicious use of antibiotics are necessary means in attempting to control the spread of C difficile infection. Attempts at making an effective human vaccine are currently under way.Keywords
This publication has 12 references indexed in Scilit:
- Bacterial infections of the colonCurrent Treatment Options in Gastroenterology, 2000
- Pseudomembranous Colitis: An UpdateCanadian Journal of Gastroenterology and Hepatology, 2000
- Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoeaThe Lancet, 1998
- Immune response to Clostridium difficile infectionEuropean Journal of Gastroenterology & Hepatology, 1996
- Community-Acquired Clostridium difficile-Associated DiarrheaClinical Infectious Diseases, 1995
- Acquisition of Clostridium difficile by Hospitalized Patients: Evidence for Colonized New Admissions as a Source of InfectionThe Journal of Infectious Diseases, 1992
- Nosocomial Clostridium difficile colonisation and diseaseThe Lancet, 1990
- Treatment with bovine hyperimmune colostrum of cryptosporidial diarrhea in AIDS patientsAIDS, 1990
- Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-upThe Lancet, 1990
- Protection by Milk Immunoglobulin Concentrate against Oral Challenge with EnterotoxigenicEscherichia coliNew England Journal of Medicine, 1988